Institute for Experimental Cellular Therapy


Prof. Dr. med. Katharina Fleischhauer 



Elke Stratmann


+49 201 723 4583


+49 201 723 4546



The Institute for Experimental Cellular Therapy is dedicated to the transplantation of allogeneic tissues, in particular of hematopoietic stem cells (HSC). HSC transplantation represents the only possibility of definitive cure for many patients affected by tumors of the blood system, such as leukemia, and its clinical application is increasing around the world. Besides offering diagnostic services for allogeneic HSC transplantation, the Institute for Experimental Cellular Therapy is focused on translational research aimed at unraveling the biological mechanisms underlying the clinical success or failure of allogeneic HSC transplantation.


Diagnostic Services

  • Determination of host-donor chimersim by quantitative PCR fort patient follow-up after allogeneic HSC transplantation
  • Immunogenetic counseling for the optimization of donor selection in allogeneic HSC transplantation



  • Cellular and humoral alloreactivity and its role in transplantation
  • Molecular and functional polymorphism of the HLA system and immune-related genes



The institute employs three staff research assistants, a physician scientist (board in hematology-internal medicine), a PhD student and a technician as well as several Medical/Bachelor/Master students.


back to the overview